SCHEMBL4444462

SCHEMBL4444462

CCC(=O)Nc1ccc(/C=C/c2ccc(Cl)cc2Cl)cc1C(=O)O.O=C(O)c1cc(COc2ccc(Br)cc2Br)ccc1NC(=O)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 4/20 0.42
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 4/20 0.37
POLB P06746 3/20 0.37
TP53 P04637 2/20 0.37
LMNA P02545 2/20 0.37
MCL1 Q07820 2/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PPARD Q03181 1/20 0.36
HSP90AA1 P07900 1/20 0.36
STAT3 P40763 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4444468 1.00 MRGPRX4 (0.42) MRGPRX4MEN1KMT2AALDH1A1KDM4E
SCHEMBL1826216 0.81 MRGPRX4 (0.51) MRGPRX4MEN1KMT2AALDH1A1KDM4E
SCHEMBL1826264 0.81 KDM4E (0.46) MRGPRX4MEN1KMT2AALDH1A1KDM4E
SCHEMBL1827181 0.80 ALDH1A1 (0.50) KMT2AALDH1A1KDM4EMAPK1RAB9A
SCHEMBL1825983 0.80 ALDH1A1 (0.50) KMT2AALDH1A1KDM4EMAPK1RAB9A
SCHEMBL1822283 0.79 MRGPRX4 (0.56) MRGPRX4MEN1KMT2AALDH1A1KDM4E
SCHEMBL1825164 0.79 KDM4E (0.60) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL1825158 0.79 KDM4E (0.60) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL1825552 0.79 POLB (0.52) MRGPRX4MEN1KMT2AALDH1A1KDM4E
SCHEMBL1825840 0.77 MRGPRX4 (0.51) MRGPRX4MEN1KMT2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118051-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF Chelsea Therapeutics, Inc. (US) 2009-11-18 EP claimed
WO-2008097180-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF CHELSEA THERAPEUTICS, INC. (US) 2008-08-14 WO claimed